Business Pillars


Domestic Market


Beta drugs Ltd. gained the confidence of Oncologists across India & build Leadership position.

Market Leaders

Card Image

Leader in SOLID TUMOR

Card Image

Leader in HEMATOLOGY


Card Image

Leader in SUPPORTIVE CARE

Card Image

Leader in SUPPORTIVE CARE


Market Reach

Beta Drugs has a leadership position in Indian Oncology Market with 100 SKU's.

Products are available in all major Corporates Hospitals and Government Institutes.

Contract Manufacturing


Beta Drugs Ltd is acknowledged as a high quality contract manufacturing company by many leading pharmaceutical companies in India.


Clientele Base of 49+ Companies

Our impressive clientele for contract manufacturing has big names of the pharma industry in India.



At Beta Drugs Ltd, we take our partners very seriously. We deliver high-quality complex oncology products to diverse markets quickly and cost-effectively. Working in close collaboration with our clients, Beta Drugs Ltd can offer a superior range of products, besides end-to-end support, throughout the production process.
We are able to do this by assigning a dedicated, fully responsive resource unit to each client. This unit provides all kinds of research and logistical support and quality assurance and marketing-related assistance to our clients.

Quality Policy


We stringently adhere to implementing quality management systems and are committed towards making improvements to the same.

We are committed to excellent quality and to being the best in the industry.


Quality Assurance:

The objective of quality assurance team is to ensuring that our manufactured products are of the highest quality to achieve maximum efficacy. Our Team continuously review our various operations to make them more efficient, relevant with changing international scenario.



Quality Control:

The Quality Control (QC) department is well equipped with modern instruments and systems for carrying out analysis of the raw materials, packing materials, in process/intermediate samples, finished drug substances, and microbiological analysis. Each raw material and packing material manufactured and supplied is analyzed as per laid down specifications.

Specifications, standard test methods (Method of Analysis) and acceptance criteria are well documented and revised by the Quality Control department from time to time. .

Global Reach



"With our R&D and marketing co-operations, we are determined to continue consolidating our position in the global pharmaceutical mark"


We are now globally represented by our subsidiaries or sales partners in over 15 Countries: Uzbekistan, Nigeria, Kenya, Uganda, Sri Lanka, Nepal, Myanmar, Yemen, Honduras, Venezuela, Tanzania, Ethiopia, Philippines, Malaysia & Ivory coast.

More than 50 products have been registered in these countries.

With our research, development and marketing co-operations, we are determined to continue consolidating our position in the global pharmaceutical market. Our innovative, internationally oriented marketing strategy forms a sound basis for these efforts

In October 2018, Beta Drugs entered into a joint venture with SILUJIN Private Co. Ltd, to manufacture Oncology drugs in Uzbekistan. Beta Drugs is first Indian company to manufacture Oncology drugs in Uzbekistan.

API Development


It all starts here....


API DEVELOPMENT

Strong In-House API Development with backward Integration provides us the key competitive advantage.

We always intend to improve process that can give cost advantage. Our team is constantly working on novel route of synthesis & process elegance. We have also adopted environment friendly green & safe technology.


  • DOCETAXEL TRIHYDRATE
  • ERLOTINIB HYDROCHLORIDE
  • GEFITINIB
  • LAPATANIB DITOSYLATE
  • PEMETREXED DISODIUM HEPTAHYDRATE
  • SORAFENIB TOSYLATE
  • TEMOZOLOMIDE
  • ENZALUTAMIDE
  • AXITINIB
  • SUNITINIB
  • LENVATINIB
  • METHOTREXATE
  • AZACITIDINE
  • HYDROXYUREA
  • IMATINIB MESYLATE
  • LENALIDOMIDE
  • BORTEZOMIB
  • DASATINIB
  • BENDAMUSTINE HYDROCHLORIDE
  • PLERIXAFOR
  • ETOPOSIDE
  • BICALUTAMIDE
  • IRINOTECAN
  • FULVESTRANT
  • ANASTROZOLE
  • NINTEDANIB
  • ABIRATERONE
  • BOSUTINIB
  • PAZOPANIB
  • APREPITANT
  • HYDROXYCARBAMIDE
  • ZOLEDRONIC ACID
  • FOS-APREPITANT